Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: J Clin Immunol. 2013 Mar 20;33(5):991–1001. doi: 10.1007/s10875-013-9882-5

Figure 1.

Figure 1

Patient 1 (a) CT chest showing necrotizing mediastinal lymphadenitis and extensive parenchymal disease due to refractory MAC infection; (b) After 1 year of treatment with IFN-α, cervical, mediastinal and parenchymal disease had resolved completely.